OrgPad logo

Week 6

Created by Rose Kamille Colmenar

COPD, RV Failure, Pneumothorax

Week 6

Interventions

Chronic Bronchitis

Hyper secretions of mucus and chronic productive cough at least  3 months out of a year for at least 2 consecutive years

produce more mucous "cupfull of mucous

Emphysema

an abnormal enlargement of the airspaces beyond the terminal bronchioles with destruction of the walls of the alveoli (parenchymal destruction)

Exposure to irritants

Intervention

Quit Smoking

Assessment

an abnormal enlargement of the airspaces beyond the terminal bronchioles with destruction of the walls of the alveoli (parenchymal destruction)

Assessment/ Diagnostic

Development of cough, shortness of breath

Airway epithelium inflammation

Alpha 1 Antitrypsin Deficiency

Smoking

Smoking history

expressed as “pack/years”: the number of packs smoked per day times the number of years of smoking. A person who has smoked an average of 2 packs per day for 20 years has a smoking history of 40 pack/years.

More sputum amount

Frank purulent sputum

Chronic mucus hypersecretion has been implicated as a cause of lung function decline, exacerbations, and infections.

Intervention

Help patient to identify irritants in the environment and together develop a plan to minimize exposure

Mucous gland hyperplasia

Bronchial muscle hyperplasia

Decreased inhibition of proteolytic enzymes

more proteolytic enzyme activity. Break downs protein in the lungs (breakdown lung tissue)

 

protease digest proteins

Increased neutrophils in lung parenchyma/tissue

Increase size and number of mucous glands and goblet cells

Ciliary dysfunction

cant clear out secretions. dust particles, bacteria, viruses = prone to infections

Bronchial wall narrowing

Assessment/ Diagnostic

Development of wheeze heard with auscultation

Damage to bronchioles and alveolar walls

Release of proteolytic enzymes from neutrophils

similar to genetic disease

Medications

Mucus thicker/more tenacious

great place for bacteria to grow

reduced mucus function

Airflow limitation

Intervention???

bronchodilator

tripod

putrsed lip breathing

Interventions

Alveolar septum destruction

Assessment/ Diagnostic???

Assessment

Bronchospasm, Dyspnea, Productive cough

Bronchospasm: wheezing

 

Elimination of portions of pulmonary capillary bed

big "sacky" alveoli = less surface area

Increase volume of air in acinus

Article Related

Intervention

Adequate hydration (2 to 3 L/day) is indicated to keep the mucous membranes moist and thereby facilitate the removal of secretions as long as not contraindicated by cardiac, liver, or kidney disease. Supplemental oxygen is administered as necessary.

Frequent infectious exacerbations

Disturbance in gas exchange

Hyperinflated Alveoli (bullae)

Bullae are enlarged airspaces that do not contribute to ventilation but occupy space in the thorax. Bullae may compress areas of healthier lung and impair gas exchange.

Assessment/ Diagnostic

Dyspnea: an awareness of uncomfortable breathing that may vary in intensity

Chronic cough and Sputum production: severe and often interferes with the person’s activities of daily living

Diagnosis: history, physical exam, pulmonary function test (PFT)

Spirometry

Total lung capacity

ABG

Chest xray

COPD SYMPTOMS

In early stage disease, the person may note an early morning cough productive of a small to moderate amount of white to clear sputum. During exacerbations, an increase in the amount and viscosity of sputum may occur, and the sputum may change color.

Continued edema/narrowing of bronchial walls

Loss of elastic recoil

Continued alveolar damage and weakening of alveolar walls

Symptom of increased WOB

Assessment

Intervention

Bronchodilators: relieve bronchospasm, reduce airway obstruction, and aid in secretion clearance

Corticosteroid: used for acute exacerbations with severe symptoms not affected by bronchodilator

Mucolytics

Red Flag

Difficult expiration

Airway collaps in expiration

Pickle or Chest PT

Formation of blebs

Cause bleb rupture: increase pulmonary pressure, severe coughing, ventilator use (positive pressure)

Assessment/ Diagnostic???

Tiotropium (LAMA)

Long acting muscarinic antagonist

aka anticholinergic bronchodilator

maintenance med used on regular basis

V/Q Mismatch

With dead air space, there is ventilation without perfusion, resulting in a high ventilation–perfusion ratio

Intervention

Breathing Training

Pursed-lip breathing helps slow exhalation and is thought to prevent the collapse of the small airways, effectively allowing more air to be exhaled and decreasing hyperinflation.

Fan

Diaphragmatic breathing

Inspiratory muscle training

Pacing

Shunting

Risk of bleb rupture

weakness on lung wall

Intervention

Long-term oxygen therapy (worn more than 15 hours per day) was associated with increased survival, improved quality of life, a modest reduction in pulmonary arterial pressure, and decreased dyspnea.

Intervention

Careful assessment for pneumothorax including decreased lung sounds, change in oxygenation, chest pain and report variations to provider

 

Rapid response teams or emergency services should be initiated

 

bullae can be surgically removed

LVRS involves the removal of a portion of the diseased lung parenchyma. Successful LVRS results in reduced hyperinflation and improvement in the elastic recoil and diaphragmatic mechanics.

Assessment/ Diagnostic

Pulse Ox - assess response to O2 therapy

ABG - assess PaCO2 (the breathing drive for COPD patients)

 

Pneumothorax

MEDICAL EMERGENCY

Hypercapnea

Interventions

Increased Pulmonary Vascular Resistance

Resistance to pulmonary blood flow is increased, forcing the right ventricle to maintain a higher and a higher pressure in the pulmonary artery.

Hyperventilation

Polycythemia

RBC to be able to carry more oxygen.

kidney involvement

Hypoxemia stimulates erythropoeitin to produce more RBC

HIgh hematocrit

Increased RV Pressure during systole

Respiratory fatigue

Anemia of Chronic Illness

overides polycytemia

pt are more likely to be anemic

RV Hypertrophy

???

The diagnosis of pulmonary hypertension associated with COPD is suspected in patients complaining of dyspnea and fatigue that appear to be disproportionate to pulmonary function abnormalities.

Enlargement of the central pulmonary arteries on chest radiograph, echocardiography suggestive of right ventricular enlargement and elevated plasma brain natriuretic peptide (BNP) may be present.

BNP>100 = HF/ventricular problems

Increased RA and RVEDP

Right Atrium

Right Ventricular End Diastolic Pressure

Cor Pulmonale

  1. Shunts blood to parts of lung that can increase perfusion
  2.  all capilaries will vasoconstrict with all tenatious secreations putting a lot of work on the right side of the heart 
  3. pulmonary 
  4. bronchial system - arise from aorta to deliver oxygenated blood to the lungs
  5. bronchial venous drainage goes into pulmonary vein in the left atrium. The systemic blood is never 100%

Increased systemic venous pressure

dependent edema

difficult ambulation

Intervention

Exercise

increased visceral edema

weight gain

Assessment/ Diagnostic

decreased activity, muscle weakness, and fatigue

Assessment/ Diagnostic

Difficult digestion, abosorption, and abdominal pain

hepatic engorgement

Intervention

Obese will continue, no weight loss

Anorexia

unable to meet normal metabolic body requirements

Hepatomegaly

RUQ pain

Intervention

High Protein

High Caloric Diet

Low/Controlled Carb - metabolize into CO2

Obese will continue, no weightloss

Malnutrition

Ascites

Splenomegaly

Impaired liver function

Elevated liver levels

Disruption in RBC, Platelets

thrombocytopenia

Decreased protein stores

Impaired protein synthesis

 

 

Clotting factors are proteins that are synthesized in the liver.

Coagulopathy